Drug intelligence / Profile preview

sanggua (Tongji Hospital)

Development stage
Unknown
Lead developer
Tongji Hospital
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Sanggua is a Traditional Chinese Medicine (TCM) formula developed as a tablet for the treatment of impaired glucose tolerance (IGT) and mild type 2 diabetes mellitus (T2DM). The formula is composed of five primary botanical ingredients: mulberry leaf (*Folium Mori*), bitter melon (*Fructus Momordicae Charantiae*), kudzu root (*Radix Puerariae*), Chinese yam (*Rhizoma Dioscoreae*), and cassia seed (*Semen Cassiae*). Mechanistically, it is designed to clear heat, generate body fluids, and tonify the spleen and kidneys according to TCM principles. Modern pharmacological studies suggest that its active components, such as mulberry polysaccharides and bitter melon saponins, contribute to blood glucose reduction and lipid profile improvement. It is currently being evaluated in clinical trials led by Tongji Hospital to assess its efficacy on glycated hemoglobin (HbA1c) levels and its impact on the gut microbiota.

Brand names
Sanggua
Other names
Sanggua tablets
02

Targets

Sucrase-Isomaltase

Beyond the preview

Go deeper on sanggua (Tongji Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sanggua (Tongji Hospital).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call